Working the JP Morgan Healthcare Conference 2016: More, More, More – How Do You Like It?

It’s coming around to that big week in San Francisco again. Many love it, many eyeroll it – but the second week of January is crucial for the healthcare investing world, with the JP Morgan Healthcare Conference (#JPM16) being the main event that will draw thousands. Of course, this means the many receptions, receptions, receptions, but also this year, there are even more events […]

Read More

Event Recap: primeUC Crowns its First Startup Champions

By Dr. Karen Ring for Big3Bio California is a hotbed for promising startups in technology, healthcare and the life sciences. Many of the innovative ideas that spawn these companies originate from labs and universities. One of the leaders in scientific entrepreneurship is the University of California (UC). Among its 10 campuses, five medical centers and […]

Read More

Event Recap: Celebrating Life Science Leaders at CLSA Pantheon Awards

By Dr. Karen Ring for Big3Bio The science world might not seem as glamorous as Hollywood and the red carpet, but last night the California Life Sciences Association (CLSA) threw an awards ceremony worthy of the Oscars. With a program that included everything from beakers to bagpipe players, the 2015 CLSA Pantheon DiNA Awards honored […]

Read More

Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA – California’s first statewide trade group for biotech   Chapter […]

Read More

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part […]

Read More

Event Recap: How J&J Promotes Innovation

By Dr. Karen Ring, Big3Bio Events Correspondent How exactly does one of the largest pharmaceutical companies in the world promote scientific innovation through proactive collaboration and investment? This month’s BioScience Forum addressed that question by detailing the structure and focus of Johnson & Johnson (J&J) in an event featuring Senior Director for New Ventures, J&J Innovation, Thorsten Melcher. […]

Read More

Event Recap: Insights on the CRISPR/Cas9 Genome Editing Revolution

By Dr. Karen Ring, Big3Bio Events Correspondent It’s a pretty exciting time in the world of science. Stem cell therapies are entering human trials, CAR-T cells are bringing new hope to immuno-oncology, and advancements in genome editing technologies have put gene therapy back on the table. From a therapeutic perspective, the CRISPR/Cas9 genome editing system is […]

Read More

International Event Recap: BIO 2015 in Philadelphia

By Dr Kristophe Diaz, Big3Bio East Coast Consultant This year’s BIO Convention was held in Philadelphia at the Pennsylvania Convention Center, and the 150,000 square feet of convention space gave 1,800 exhibitors a chance to showcase their technologies, capabilities, and, for many countries and 47 states and regions, an opportunity to share a snapshot of […]

Read More

The Fascinating Saga of Elizabeth Holmes

From Nuviun.com: “In a 3-part series, Gisele Waters dives into the amazing world of Elizabeth Holmes, and the paradigm shift that her company, Theranos, is beginning to make around the consumerization of healthcare.” An excerpt: “Elizabeth Holmes has stealthily and steadily set up an operations infrastructure to make one of the biggest impacts on healthcare and […]

Read More

Event Recap: The Business of Personalized Medicine Summit

The Business of Personalized Medicine Recap of The Business of Personalized Medicine Summit, Sept. 9, 2014 Over the past 15 years, “personalized medicine” has become a buzz-phrase bandied about quite often. Yet with the recent advances in genomic sequencing and the advent of big data, the possibilities in personalized medicine are indeed becoming endless. However, […]

Read More

Our Day With Mission Bay

Big3Bio Intern Trip to Mission Bay As we stepped off of the Muni T-Line, we found ourselves at the start of Gene Friend Way, the threshold of UCSF’s Mission Bay campus. Keeping an eye on our map, we wandered past a small plaza of cafés for hungry medical and grad students and toward Koret Quad. […]

Read More

Special Feature: Q&A With Menghis Bairu, CEO of Serenus Biotherapeutics

Dr. Menghis Bairu is Founder, Chairman, and CEO of Sereneus Biotherapeutics, a specialty biopharmaceutical bringing innovative therapies to Sub-Saharan African markets. Before founding Serenus, Dr. Bairu concurrently served as EVP, Chief Medical Officer & Head of Global Development at Elan plc and president and CEO of Speranza Therapeutics, Elan’s wholly owned subsidiary formed to develop […]

Read More